The global injectable nanomedicines market is expected to grow at a significant CAGR during the forecast period (2021-2027). Nanomedicines belong to a niche area in which nanotechnology is combined with prescription drugs as well as other biomedical sciences. Injectable nanomedicines, if manufactured properly, may be taken into consideration as drugs with better efficacy and safer toxicology profiles. Nanomedicines find their applications in several clinical cases for drug delivery and drug formula.

Some of the major factors that are driving the global injectable nanomedicines market include the increasing usage of injectable nanomedicines as delivery vectors and probes for biological diagnostics, imaging and therapeutics, given their extremely small size. The smaller the surface area, the larger is the space available for chemical interaction with biomolecules. Increased focus on selective drug delivery and targeted therapies is another important factor, that is boosting the demand for the global injectable nanomedicines market during the forecast period. These medicines are witnessing high demand in research pertaining to regenerative medicines and in-situ tissue regeneration.

The global injectable nanomedicines market analysis includes some of the key market players such as Merck & Co., Inc., Osartis GmbH & Co. KG, Wyeth Pharmaceuticals Inc., Orthovita, Inc., Novartis, Abbott, Pacira Pharmaceuticals, QLT Phototherapeutics, Celgene Pharmaceutical Co. Ltd. and Amgen, Inc., among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Merck & Co., Inc., Osartis GmbH & Co. KG, Wyeth Pharmaceuticals Inc., Orthovita, Inc., and Novartis, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Injectable Nanomedicines Market by Segment

By Drug Type

• Liposomes

• Micelles

• Nanocrystals

• Polymeric Nanoparticles

• Metallic Nanoparticles

• Mesoporous Silica Nanoparticles

• Others 

By Application

• Cancers

• Central Nervous System Diseases

• Cardiovascular diseases

• Infection Control

• Inflammatory Diseases

• Others

By End-User

• Hospitals

• Ambulatory Surgical Centers

• Clinics

• Specialized Drugs R&D Institutes

• Managed Care Organizations

Global Injectable Nanomedicines Market by Region